OCLASSEN GLENN A 4
4 · Verrica Pharmaceuticals Inc. · Filed Jun 18, 2018
Insider Transaction Report
Form 4
OCLASSEN GLENN A
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-06-14+17,502→ 17,502 totalExercise: $15.00Exp: 2028-06-14→ Common Stock (17,502 underlying)
Footnotes (1)
- [F1]1/3 of the total shares subject to the option shall vest on June 14, 2019 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.